학술논문
Relationship of C-reactive protein reduction to cardiovascular event reduction following treatment with canakinumab: a secondary analysis from the CANTOS randomised controlled trial
Document Type
Article
Author
Ridker, Paul M; MacFadyen, Jean G; Everett, Brendan M; Libby, Peter; Thuren, Tom; Glynn, Robert J; Kastelein, John; Koenig, Wolfgang; Genest, Jacques; Lorenzatti, Alberto; Varigos, John; Siostrzonek, Peter; Sinnaeve, Peter; Fonseca, Francisco; Nicolau, Jose; Gotcheva, Nina; Yong, Huo; Urina-Triana, Miguel; Milicic, Davor; Cifkova, Renata; Vettus, Riina; Anker, Stephan D; Manolis, Athanasios J; Wyss, Fernando; Forster, Tamas; Sigurdsson, Axel; Pais, Prem; Fucili, Alessandro; Ogawa, Hisao; Shimokawa, Hiroaki; Veze, Irina; Petrauskiene, Birute; Salvador, Leon; Cornel, Jan Hein; Klemsdal, Tor Ole; Medina, Felix; Budaj, Andrzej; Vida-Simiti, Luminita; Kobalava, Zhanna; Otasevic, Petar; Pella, Daniel; Lainscak, Mitja; Seung, Ki-Bae; Commerford, Patrick; Dellborg, Mikael; Donath, Marc; Hwang, Juey-Jen; Kultursay, Hakan; Flather, Marcus; Ballantyne, Christie; Bilazarian, Seth; Chang, William; East, Cara; Forgosh, Les; Harris, Barry; Ligueros, Monica
Source
In The Lancet 27 January-2 February 2018 391(10118):319-328
Subject
Language
ISSN
0140-6736